Measurement of perfusion using the first-pass dynamic susceptibility- weighted contrast-enhanced (DSC) MRI in neurooncology: Physical basics and clinical applications;Perfusionsmessung mit der T2*-kontrastmitteldynamik in der neuroonkologie: Physikalische grundlagen und klinische anwendungen

Radiologe

Volumn 45, Issue 7, 2005, Pages 618-632

  Weber, M A ^a   Risse, F ^a   Giesel, F L ^a   Schad, L R ^a   Kauczor, H U ^a   Essig, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Brain tumors; DSC MRI; MRI; Perfusion

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOBUTROL; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERIDOL;

ANALYTICAL PARAMETERS; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN METASTASIS; BRAIN TISSUE; CANCER GRADING; CANCER GROWTH; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM TUMOR; CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DILUTION; GLIOMA; HUMAN; INFECTION; LYMPHOMA; NERVOUS SYSTEM TUMOR; NEUROIMAGING; PATIENT MONITORING; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; RADIATION NECROSIS; RADIATION PHYSICS; SIGNAL PROCESSING; STEREOTAXIC SURGERY; THEORY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; ALGORITHM; BRAIN; BRAIN CIRCULATION; BRAIN TUMOR; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCINTISCANNING; VASCULARIZATION;

ALGORITHMS; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

EID: 23844498705     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-004-1048-2     Document Type: Article

References (68)

1. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, Rosen BR (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
2. Axel L (1980) Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology 137:679-686
3. Balzer T (1999) Kontrastmittel. In: Reimer P, Parizel PM, Stichnoth FA (Hrsg) Klinische MR-Bildgebung: Eine praktische Anleitung. Springer, Berlin Heidelberg New York, S 41-53
4. Barbier EL, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imaging 13:496-520
5. Benner T, Heiland S, Erb G, Forsting M, Sartor K (1997) Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 15:307-317
6. Bozzao A, Floris R, Baviera ME, Apruzzese A, Simonetti G (2001) Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol 22:1030-1036
7. Brüning R, Berchtenbreiter C, Holzknecht N, Essig M, Wu RH, Simmons A, Heuck A, Maschek A, Meusel M, Williams SCR, Cox TS, Knopp MV, Reiser M (2000) Effects of three different doses of a bolus injection: assessment of rCBV maps in a blinded reader study. AJNR Am J Neuroradiol 21:1603-1610
8. Brüning R, Weber J, Wu RH, Kwong KK, Hennig J, Reiser M (1995) Echo-Planar Imaging des Gehirns. Radiologe 35:902-910
9. Bühring U, Herrlinger U, Krings T, Thiex R, Weller M, Küker W (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393-396
10. Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D (2000) Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR Am J Neuroradiol 21:881-890
11. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29
12. Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A, Litt AW, Zagzag D (2001) Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 22:1109-1116
13. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiologic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12:329-340
14. Essig M, Lodemann KP, LeHuu M, Schönberg SO, Hübener M, van Kaick G (2002) Comparison of multihance and gadovist for cerebral MR perfusion imaging in healthy volunteers. Radiologe 42:909-915
15. Essig M, Schönberg SO, Schlemmer HP, Metzner R, van Kaick G (2000) Funktionelle Magnetresonanztomographie in der Neuroradiologie. Radiologe 40:849-857
16. Essig M, Waschkies M, Wenz F, Debus J, Hentrich HR, Knopp MV (2003) Assessment of brain metastases by means of dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology 228:193-199
17. Essig M, Wenz F, Scholdei R, Bruning R, Berchtenbreiter C, Meurer M, Knopp MV (2002) Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas. Effect of contrast medium extravasation. Acta Radiol 43:354-359
18. Fiebach JB, Schellinger PD (2002) Modern nuclear magnetic resonance techniques in stroke. Nervenarzt 73:104-116
19. Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M (2000) Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 48:53-58
20. Fuss M, Wenz F, Essig M, Muenter M, Debus J, Herman TS, Wannenmacher M (2001) Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 51:478-482
21. Gruys ME, Back TC, Subleski J, Wiltrout TA, Lee JK, Schmidt L, Watanabe M, Stanyon R, Ward JM, Wigginton JM, Wiltrout RH (2001) Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype. Cancer Res 61:6255-6263
22. Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342:163-166
23. Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R, Sartor K (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119-122
24. Hartmann M, Sartor K (1997) Primary malignant lymphoma of the brain. Radiologe 37:42-50
25. Hawighorst H, Engenhart R, Knopp MV, Grandy M, Essig M, Miltner P, Fuss M, van Kaick G (1997) Intracranial menningeomas: time and dose dependent effects of irradiation on blood flow, vascular permeability and interstitial space monitored by dynamic MR imaging. Magn Reson Imag 15:423-432
26. Hawighorst H, Knopp MV, Debus J, Hoffmann U, Grandy M, Griebel J, Zuna I, Essig M, Schoenberg SO, DeVries A, Brix G, van Kaick G (1998) Pharmakokinetic MR imaging for prediction of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imag 16:225-234
27. Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K (1999) Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 17:21-27
28. Huber PE, Hawighorst H, Fuss M, van Kaick G, Wannenmacher MF, Debus J (2001) Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 49:1339-1349
29. Jezzard P, Balaban RS (1995) Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med 34:65-73
30. Kandil A, Khafaga Y, ElHusseiny G, Allam A, Jamshed A, Schultz H (1999) Low-grade astrocytoma-a retrospective analysis of 102 patients. Acta Oncol 38:1051-1056
31. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB (1987) Stereotactic histologic correlations of computed tomography and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62:450-459
32. Kirchin MA, Pirovano GR Spinazzi A (1998) Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 33:798-809
33. Kleihues P, Burger PC, Scheithauer BW (1999) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York
34. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
35. Kostler H, Becker H (2001) Quantitative multi-slice imaging of perfusion of the brain. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 173:18-23
36. Kovar DA, Lewis M, Karczmar GS (1998) A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging 8:1126-1134
37. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer Statistics. CA Cancer J Clin 49:8-31
38. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721
39. Meier P, Zierler KL (1954) On the theory of the indicator-dilution method for measurement of blood flow and volume. Appl Physiol 6:731-744
40. Nakagawa T, Tanaka R, Takeuchi S, Takeda N (1998) Haemodynamic evaluation of cerebral gliomas using XeCT. Acta Neurochir (Wien) 140:223-233
41. Nasel C, Schindler E (1998) Xenon-CT and perfusion MRI in the diagnosis of cerebral gliomas. Radiologe 38:930-934
42. Østergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, Weisskoff RM, Gonzalez RG, Gyldensted C, Rosen BR (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 90:300-305
43. Østergaard L, Weiskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996) High resolution measurement of crebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36:715-725
44. Østergaard L, Sorensen AG, Kwong KK, Weiskoff RM, Gyldensted C, Rosen BR (1996) High resolution measurement of crebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 36:726-736
45. Pahernik S, Griebel J, Botzlar A, Gneiting T, Brandl M, Dellian M, Goetz AE (2001) Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging. Br J Cancer 85:1655-1663
46. Preston-Martin S (1999) Epidemiology. In: Berger, Wilson (eds) The gliomas. Saunders, Philadelphia, pp 2-11
47. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193:637-641
48. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265
49. Schellinger PD, Fiebach JB, Hacke W (2003) Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34:575-583
50. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 22:1316-1324
51. Scholdei R, Wenz F, Essig M, Fuss M, Knopp MV (1999) Simultane Bestimmung der arteriellen Inputfunktion für die dynamische susceptibilitä tsgewichtete Magnetresonanztomographie aus der A. carotis interna und der A. cerebri media. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 171:38-43
52. Simonsen CZ, Østergaard L, Smith DF, Vestergaard-Poulsen P, Gyldensted C (2000) Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking. J Magn Reson Imaging 12:411-416
53. Sorensen AG, Reimer P (2000) Cerebral MR perfusion imaging: principles and current applications. Thieme, Stuttgart New York
54. Speck O, Chang L, DeSilva NM, Ernst T (2000) Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques. J Magn Reson Imaging 12:381-387
55. Stewart GN (1894) Researches on the circulation time in organs and on the influences which affect it, parts I-III. J Physiol (London) 15:1
56. Su MY, Muhler A, Lao X, Nalcioglu O (1998) Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med 39:259-269
57. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479-1486
58. Sugahara T, Korogi Y, Shigematsu Y, Hirai T, Ikushima I, Liang L, Ushio Y, Takahashi M (1999) Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 23:232-237
59. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901-909
60. Uchino A, Hasuo K, Mizushima A, Matsumoto S, Mihara F, Jimi M, Takahashi M, Masuda K (1996) Intracranial metastasis of renal cell carcinoma: MR imaging. Radiat Med 14:71-76
61. Uematsu H, Maeda M, Sadato N, Matsuda T, Ishimori Y, Koshimoto Y, Kimura H, Yamada H, Kawamura Y, Yonekura Y, Itoh H (2001) Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol 22:1915-1919
62. Vaupel P (1994) Blood flow and metabolic microenvironment of brain tumors. J Neurooncol 22:261-267
63. Warmuth C, Günther M, Zimmer C (2003) Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 228:523-532
64. Weber MA, Lichy MP, Külkens S, Steiner T, Hartmann M (2003) Acute headache and left unilateral symptoms. Radiologe 43:319-321
65. Weber MA, Lichy MP, Thilmann C, Günther M, Bachert P, Maudsley AA, Delorme S, Schad LR, Debus J, Schlemmer HP (2003) Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy. Radiologe 43:388-395
66. Wenz F, Rempp K, Hess T, Debus J, Brix G, Engenhart R, Knopp MV, van Kaick G, Wannenmacher M (1996) Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 166:187-193
67. Wiestler OD (1998) Pathologische Anatomie und WHO-Klassifikation der Tumoren des Nervensystems. In: Schlegel U, Westphal M (Hrsg) Neuroonkologie: diagnostischer und therapeutischer Leitfaden für Neurologen, Neurochirurgen, Onkologen und Radioonkologen. Thieme, Stuttgart New York, S 4-46
68. Zierler KL (1962) Circulation times and the theory of indicator-dilution methods for determining blood flow and volume. In: Handbook of physiology. Williams & Wilkins, Baltimore, pp 585-615